跳到正文

TCG Crossover Management, LLC 13F 持仓 · 2026年Q2

TCG Crossover Management 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 54 只证券,申报市值合计 41.61 亿美元。前几大持仓:ABVX(19.24%)、TNGX(6.82%)、CGON(6.27%)。本季前 25 大持仓中:新建仓 3 只、增持 1 只、减持 5 只。

排名代码公司市值占组合股数变动
1ABVXABIVAX SA AMERICAN DEPOSITARY SHARES$800.6M19.24%6.0M减持
2TNGXTANGO THERAPEUTICS INC$283.9M6.82%9.1M减持
3CGONCG ONCOLOGY INC$260.8M6.27%3.7M持平
4COGTCOGENT BIOSCIENCES INC$187.9M4.52%4.9M减持
5IMVTIMMUNOVANT INC$171.8M4.13%4.5M持平
6SYRESPYRE THERAPEUTICS INC$168.7M4.06%1.9M持平
7DNTHDIANTHUS THERAPEUTICS INC$163.4M3.93%1.7M持平
8MIRMMIRUM PHARMACEUTICALS INC$124.3M2.99%1.1M持平
9ZLABZAI LAB LTD-ADR$116.6M2.80%6.1M新建仓
10AMLXAMYLYX PHARMACEUTICALS INC$112.1M2.70%6.2M持平
11GLUEMONTE ROSA THERAPEUTICS INC$111.9M2.69%4.6M持平
12BCRXBIOCRYST PHARMACEUTICALS INC$110.2M2.65%11.0M持平
13VORVOR BIOPHARMA INC$104.4M2.51%5.7M持平
14TYRATYRA BIOSCIENCES INC$103.8M2.49%3.2M持平
15DYNDYNE THERAPEUTICS INC$102.5M2.46%4.6M持平
16IRONDISC MEDICINE INC$98.1M2.36%1.3M持平
17RLAYRELAY THERAPEUTICS INC$80.0M1.92%4.3M持平
18SVRASAVARA INC$76.2M1.83%12.4M持平
19AURAAURA BIOSCIENCES INC$67.7M1.63%9.5M新建仓
20RVMDREVOLUTION MEDICINES INC$63.8M1.53%340,899减持
21TRAXFIRST TRACKS BIOTHERAPEUTICS$58.3M1.40%2.9M新建仓
22KODKODIAK SCIENCES INC$56.3M1.35%1.4M持平
23AVTXAVALO THERAPEUTICS INC$55.8M1.34%3.0M增持
24LBRXLB PHARMACEUTICALS INC$47.0M1.13%1.4M减持
25IPSCCENTURY THERAPEUTICS INC$43.4M1.04%17.8M持平

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR